Minocycline Hydrochloride Patent Expiration

Minocycline Hydrochloride was first introduced by Triax Pharmaceuticals Llc in its drug Minocin on Approved Prior to Jan 1, 1982. Other drugs containing Minocycline Hydrochloride are Zilxi, Minolira, Minocycline Hydrochloride, Ximino, Arestin, Amzeeq, Solodyn. 32 different companies have introduced drugs containing Minocycline Hydrochloride.

Minocycline Hydrochloride Patents

Given below is the list of patents protecting Minocycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Amzeeq	US10398641	Compositions and methods for treating rosacea and acne	Sep 08, 2037	Journey
Amzeeq	US10849847	Compositions and methods for treating rosacea and acne	Sep 08, 2037	Journey
Minolira	US11103517	Pharmaceutical compositions for minocycline	Apr 07, 2036	Epi Hlth
Minocin	US11944634	Tetracycline compositions	Oct 16, 2032	Rempex
Solodyn	US9192615	Method for the treatment of acne and certain dosage forms thereof	Nov 17, 2031	Bausch
Minocin	US9084802	Tetracycline compositions	May 12, 2031	Rempex
Minocin	US9278105	Tetracycline compositions	May 12, 2031	Rempex
Amzeeq	US10086080	Topical tetracycline compositions	Oct 01, 2030	Journey
Amzeeq	US10137200	Surfactant-free water-free foamable compositions, breakable foams and gels and their uses	Oct 01, 2030	Journey
Amzeeq	US10213512	Topical tetracycline compositions	Oct 01, 2030	Journey
Amzeeq	US10265404	Compositions, gels and foams with rheology modulators and uses thereof	Oct 01, 2030	Journey
Amzeeq	US10517882	Method for healing of an infected acne lesion without scarring	Oct 01, 2030	Journey
Amzeeq	US10821187	Compositions, gels and foams with rheology modulators and uses thereof	Oct 01, 2030	Journey
Amzeeq	US8865139	Topical tetracycline compositions	Oct 01, 2030	Journey
Amzeeq	US8945516	Surfactant-free water-free foamable compositions, breakable foams and gels and their uses	Oct 01, 2030	Journey
Amzeeq	US8992896	Topical tetracycline compositions	Oct 01, 2030	Journey
Amzeeq	US9675700	Topical tetracycline compositions	Oct 01, 2030	Journey
Zilxi	US10213512	Topical tetracycline compositions	Oct 01, 2030	Journey
Zilxi	US10265404	Compositions, gels and foams with rheology modulators and uses thereof	Oct 01, 2030	Journey
Zilxi	US10322186	Topical tetracycline compositions	Oct 01, 2030	Journey
Zilxi	US10946101	Surfactant-free water-free foamable compositions, breakable foams and gels and their uses	Oct 01, 2030	Journey
Zilxi	US8865139	Topical tetracycline compositions	Oct 01, 2030	Journey
Zilxi	US8945516	Surfactant-free water-free foamable compositions, breakable foams and gels and their uses	Oct 01, 2030	Journey
Zilxi	US8992896	Topical tetracycline compositions	Oct 01, 2030	Journey
Zilxi	US9675700	Topical tetracycline compositions	Oct 01, 2030	Journey
Solodyn	US7541347	Minocycline oral dosage forms for the treatment of acne	Apr 02, 2027	Bausch
Solodyn	US7544373	Minocycline oral dosage forms for the treatment of acne	Apr 02, 2027	Bausch
Ximino	US7541347	Minocycline oral dosage forms for the treatment of acne	Apr 02, 2027	Journey
Ximino	US7544373	Minocycline oral dosage forms for the treatment of acne	Apr 02, 2027	Journey
Solodyn	US7919483	Method for the treatment of acne	Mar 07, 2027	Bausch
Ximino	US7919483	Method for the treatment of acne	Mar 07, 2027	Journey
Solodyn	US7790705	Minocycline oral dosage forms for the treatment of acne	Jun 24, 2025	Bausch
Solodyn	US8252776	Minocycline oral dosage forms for the treatment of acne	Jun 24, 2025	Bausch
Solodyn	US8268804	Minocycline oral dosage forms for the treatment of acne	Jun 24, 2025	Bausch
Solodyn	US8722650	Extended-release minocycline dosage forms	Jun 24, 2025	Bausch
Ximino	US7790705	Minocycline oral dosage forms for the treatment of acne	Jun 24, 2025	Journey
Ximino	US8252776	Minocycline oral dosage forms for the treatment of acne	Jun 24, 2025	Journey
Ximino	US8268804	Minocycline oral dosage forms for the treatment of acne	Jun 24, 2025	Journey
Arestin	US6682348	Dispensing apparatus and cartridge	Mar 29, 2022 (Expired)	Orapharma
Arestin	US7699609	Dispensing apparatus and cartridge with deformable tip	Mar 29, 2022 (Expired)	Orapharma
Solodyn	US5908838	Method for the treatment of acne	Feb 19, 2018 (Expired)	Bausch
Ximino	US5908838	Method for the treatment of acne	Feb 19, 2018 (Expired)	Journey

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Minocycline Hydrochloride's patents.

Latest Legal Activities on Minocycline Hydrochloride's Patents

Given below is the list recent legal activities going on the following patents of Minocycline Hydrochloride.

Activity	Date	Patent Number

Payment of Maintenance Fee, 12th Year, Large Entity	20 Feb, 2024	US8268804(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity	23 Jan, 2024	US8252776(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity	20 Apr, 2023	US9192615
Payment of Maintenance Fee, 4th Yr, Small Entity	19 Dec, 2022	US10322186
Payment of Maintenance Fee, 12th Year, Large Entity	20 Sep, 2022	US7919483(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity	23 Feb, 2022	US7790705(Litigated)
Recordation of Patent Grant Mailed Critical	16 Mar, 2021	US10946101
Patent Issue Date Used in PTA Calculation Critical	16 Mar, 2021	US10946101
Email Notification Critical	26 Feb, 2021	US10946101
Issue Notification Mailed Critical	24 Feb, 2021	US10946101

Minocycline Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue

Explore the top-performing drugs that dominate the pharmaceutical industry

View List

NCE-1 Patent Expiry in the Next 1 Year

Identify opportunities as new chemical entity (NCE-1) patents approach expiry

View List

Recently Granted Patents in EP

Find the opportunity to file Oppositions

View List

Minocycline Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Minocycline Hydrochloride. The first generic version for Minocycline Hydrochloride was by Lederle Laboratories Div American Cyanamid Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Jun 16, 2023.

Given below is the list of companies who have filed for Minocycline Hydrochloride generic, along with the locations of their manufacturing plants worldwide.

1. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 80MG BASE	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2016
EQ 45MG BASE	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2016
EQ 105MG BASE	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2016
EQ 135MG BASE (reference standard)	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2016
EQ 90MG BASE	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2016
EQ 65MG BASE	tablet, extended release	Prescription	ORAL	AB	Mar 16, 2018
EQ 115MG BASE (reference standard)	tablet, extended release	Prescription	ORAL	AB	Mar 16, 2018
EQ 55MG BASE	tablet, extended release	Prescription	ORAL	AB	Dec 19, 2019

2. ALVOGEN

Alvogen Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. All of these versions come by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Alvogen.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE	capsule	Discontinued	ORAL	N/A	Jul 31, 1990
EQ 50MG BASE	capsule	Discontinued	ORAL	N/A	Aug 14, 1990
EQ 75MG BASE	capsule	Discontinued	ORAL	N/A	Sep 15, 1999

Manufacturing Plant Locations
^New

Alvogen's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Alvogen as present at those locations.

Country

City

Firm Name

United States

Morristown

Alvogen, Inc

3. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 75MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2008
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2008
EQ 50MG BASE	capsule	Prescription	ORAL	AB	Mar 11, 2008

Manufacturing Plant Locations
^New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country

City

Firm Name

India

Sangareddy	Aurobindo Pharma Limited
Bachupally	Aurobindo Pharma Limited
Medchal	Aurobindo Pharma Ltd
Polepally, Mahaboob Nagar	Aurobindo Pharma Limited

United States

East Windsor

Aurobindo Pharma USA Inc

4. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 11 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 135MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 19, 2012
EQ 90MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 19, 2012
EQ 45MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 19, 2012
EQ 80MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 13, 2016
EQ 105MG BASE	tablet, extended release	Prescription	ORAL	AB	Jun 13, 2016
EQ 65MG BASE	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2018
EQ 115MG BASE	tablet, extended release	Prescription	ORAL	AB	Sep 28, 2018
EQ 55MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 21, 2019
EQ 75MG BASE	tablet	Prescription	ORAL	AB	May 1, 2020
EQ 100MG BASE	tablet	Prescription	ORAL	AB	May 1, 2020
EQ 50MG BASE	tablet	Prescription	ORAL	AB	May 1, 2020

Manufacturing Plant Locations
^New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country

City

Firm Name

India

Medchal

Aurobindo Pharma Ltd

5. BARR LABS INC

Barr Laboratories Inc has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 90MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Mar 17, 2009
EQ 45MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Mar 17, 2009
EQ 135MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Mar 17, 2009
EQ 65MG BASE	tablet, extended release	Discontinued	ORAL	N/A	May 18, 2012
EQ 115MG BASE	tablet, extended release	Discontinued	ORAL	N/A	May 18, 2012
EQ 105MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Apr 26, 2017
EQ 80MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Apr 26, 2017

6. BEXIMCO PHARMS USA

Beximco Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE	tablet	Prescription	ORAL	AB	May 27, 2022
EQ 50MG BASE	tablet	Prescription	ORAL	AB	May 27, 2022
EQ 75MG BASE	tablet	Prescription	ORAL	AB	May 27, 2022

7. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 135MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 30, 2011
EQ 55MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 30, 2011
EQ 45MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 30, 2011
EQ 90MG BASE	tablet, extended release	Prescription	ORAL	AB	Nov 30, 2011

8. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Dec 26, 2007
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Dec 26, 2007
EQ 75MG BASE	tablet	Prescription	ORAL	AB	Dec 26, 2007

9. IMPAX LABS

Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	capsule	Prescription	ORAL	AB	Mar 23, 1999
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Mar 23, 1999
EQ 75MG BASE	capsule	Prescription	ORAL	AB	Apr 18, 2001

10. IMPAX LABS INC

Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 45MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Feb 3, 2009
EQ 135MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Feb 3, 2009
EQ 90MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Feb 3, 2009

11. LEDERLE

Lederle Laboratories Div American Cyanamid Co has filed for 1 generic for Minocycline Hydrochloride. This eq 100mg base/vial version comes by the name MINOCIN. Given below are the details of the strengths of this generic introduced by Lederle.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE/VIAL	injectable	Discontinued	INJECTION	N/A	Approved Prior to Jan 1, 1982

12. MEDICIS

Medicis Pharmaceutical Corp has filed for 1 generic for Minocycline Hydrochloride. This eq 50mg base version comes by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Medicis.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	capsule	Discontinued	ORAL	N/A	Aug 14, 1990

Manufacturing Plant Locations
^New

Medicis's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Medicis as present at those locations.

Country

City

Firm Name

United States

Scottsdale	Medicis Pharmaceutical Corp
Scottsdale	Medicis Aesthetics Inc.

13. NEXUS PHARMS

Nexus Pharmaceuticals Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Nexus Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE/VIAL	injectable	Prescription	INJECTION	AP	Jul 22, 2022

14. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 135MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jul 20, 2010
EQ 90MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jul 20, 2010
EQ 45MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jul 20, 2010

15. RISING

Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 80MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Aug 22, 2014
EQ 105MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Aug 22, 2014
EQ 115MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jul 30, 2019
EQ 65MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jul 30, 2019
EQ 55MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Aug 21, 2019

Manufacturing Plant Locations
^New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country

City

Firm Name

United States

Flagstaff	Rising High Enterprises, LLC (DBA RisingHy)
Saddle Brook	Rising Pharmaceuticals, Inc.
Mount Morris	Rising Creek Bakery LLC
Livingston	Risingsun Iodine Products Corp.
Decatur	Rising Pharma Holdings, Inc
Fort Bragg	Rising Tide Sea Vegetables
East Brunswick	Rising Pharma Holding, Inc.
Rising Sun	Rising Sun Veterinary Clinic
Phoenix	Rising Sun Farms Inc

Mexico

Pueblo San Clemente

RISING FARMS SAPI DE CV

India

Ahmedabad

Rising Retina Clinic

16. SANDOZ

Sandoz Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 90MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 13, 2009
EQ 135MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 13, 2009
EQ 45MG BASE	tablet, extended release	Prescription	ORAL	AB	Aug 13, 2009

Manufacturing Plant Locations
^New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country

City

Firm Name

Austria

Langkampfen	Sandoz GmbH
Kundl	Sandoz GmbH

United States

Princeton	Sandoz Inc
East Hanover	Sandoz Incorporated

Spain

Les Franqueses Del Valles	Sandoz Industrial Products S.A.
Palafolls	Sandoz Industrial Products, S.A.

India

Navi Mumbai

Sandoz Private Limited

17. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 75MG BASE	tablet	Prescription	ORAL	AB	Apr 16, 2003
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Apr 16, 2003
EQ 100MG BASE (reference standard)	tablet	Prescription	ORAL	AB	Apr 16, 2003

Strength

Dosage Form

Availability

Application Pathway

TE code

Launch Date

EQ 75MG BASE

tablet

Prescription

ORAL

Apr 16, 2003

EQ 50MG BASE

tablet

Prescription

ORAL

Apr 16, 2003

EQ 100MG BASE

tablet

Prescription

ORAL

Apr 16, 2003

Manufacturing Plant Locations
^New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country

City

Firm Name

United States

East Brunswick	Strides Pharma Inc.
Chestnut Ridge	Strides Pharma, Inc.

India

Bangalore	Strides Pharma Science Limited
Puducherry	Strides Pharma Science Limited

18. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 135MG BASE	tablet, extended release	Prescription	ORAL	AB	Dec 30, 2015
EQ 80MG BASE	tablet, extended release	Prescription	ORAL	AB	Dec 30, 2015
EQ 105MG BASE	tablet, extended release	Prescription	ORAL	AB	Dec 30, 2015
EQ 45MG BASE	tablet, extended release	Prescription	ORAL	AB	Dec 30, 2015
EQ 65MG BASE	tablet, extended release	Prescription	ORAL	AB	Oct 7, 2022
EQ 55MG BASE	tablet, extended release	Prescription	ORAL	AB	Oct 7, 2022
EQ 115MG BASE	tablet, extended release	Prescription	ORAL	AB	Oct 7, 2022

Manufacturing Plant Locations
^New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country

City

Firm Name

United States

Billerica	Sun Pharmaceutical Industries, Inc.
Lexington	Sun Pharmaceutical Industries Inc
Princeton	SUN PHARMACEUTICAL INDUSTRIES INC

India

Mohali	Sun Pharmaceutical Industries Limited
Ahmednagar	Sun Pharmaceutical Industries Limited
Vadodara	Sun Pharmaceutical Industries Ltd
Bharuch	Sun Pharmaceutical Industries Ltd
Baruch	Sun Pharmaceutical Industries Ltd.
Kanchipuram	Sun Pharmaceutical Industries Limited- Madhuranthagam
Vadodara	Sun Pharmaceutical Industries Ltd.
Punjab	Sun Pharmaceutical Industries, Inc.
Malanpur, Bhind (District)	Sun Pharmaceutical Industries Limited
Vadodara	Sun Pharmaceutical Industries Limited - Karkhadi
Gurugram	Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Dadra	Sun Pharmaceutical Industries Limited
Halol	Sun Pharmaceutical Industries Ltd.
New Delhi	Sun Pharmaceutical Industries Limited

19. SUN PHARM INDS INC

Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 75MG BASE	capsule	Prescription	ORAL	AB	May 13, 2013
EQ 50MG BASE	capsule	Prescription	ORAL	AB	May 13, 2013
EQ 100MG BASE	capsule	Prescription	ORAL	AB	May 13, 2013

20. SUN PHARM INDS LTD

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 45MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Sep 25, 2014
EQ 135MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Sep 25, 2014
EQ 105MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Sep 25, 2014
EQ 90MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Sep 25, 2014
EQ 80MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Sep 25, 2014
EQ 115MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Dec 3, 2019
EQ 65MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Dec 3, 2019

21. SUN PHARM INDUSTRIES

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 75MG BASE	tablet	Discontinued	ORAL	N/A	Jan 29, 2016
EQ 50MG BASE	tablet	Discontinued	ORAL	N/A	Jan 29, 2016
EQ 100MG BASE	tablet	Discontinued	ORAL	N/A	Jan 29, 2016

22. TORRENT

Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	tablet	Prescription	ORAL	AB	Jan 6, 2004
EQ 100MG BASE	tablet	Prescription	ORAL	AB	Jan 6, 2004
EQ 75MG BASE	tablet	Prescription	ORAL	AB	Jan 6, 2004

Manufacturing Plant Locations
^New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country

City

Firm Name

India

Gandhi Nagar	Torrent Pharmaceuticals Limited
Pithampur	Torrent Pharmaceuticals Limited
Thanam	Torrent Pharmaceuticals Limited
Bharuch	Torrent Pharmaceuticals Limited
Indrad	Torrent Pharmaceuticals Limited

United States

Kalamazoo	Torrent Pharma Inc.
Basking Ridge	Torrent Pharma Inc.

23. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 100MG BASE	capsule	Prescription	ORAL	AB	Dec 30, 1991
EQ 75MG BASE	capsule	Prescription	ORAL	AB	Jun 10, 1999

24. WATSON LABS TEVA

Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 50MG BASE	capsule	Prescription	ORAL	AB	Dec 30, 1991

25. ZYDUS

Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.

Strength

Dosage Form

Availability

Application Pathway

TE code

Launch Date

EQ 100MG BASE

capsule

Prescription

ORAL

Mar 2, 1992

EQ 50MG BASE

capsule

Prescription

ORAL

Mar 2, 1992

EQ 75MG BASE

capsule

Prescription

ORAL

Aug 12, 2003

Manufacturing Plant Locations
^New

Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.

Country

City

Firm Name

India

Ankleshwar	Zydus Lifesciences Limited
Dabhasa	Zydus Lifesciences Limited
Ahmedabad	ZYDUS LIFESCIENCES LIMITED
Ahmedabad	Zydus Lifesciences Limited
Matoda	Zydus Hospira Oncology Private Ltd.
Matoda	Zydus Lifesciences Limited
Jarod	Zydus Lifesciences Limited
Thane	Zydus Lifesciences Limited
Moraiya, Ahmedabad	Zydus Lifesciences Limited
Matoda, Ahmedabad	Zydus Animal Health and Investments Limited
District Solan	Zydus Lifesciences Limited

United States

Pennington

Zydus Pharmaceuticals (USA) Inc

26. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength	Dosage Form	Availability	Application Pathway	TE code	Launch Date
EQ 45MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Nov 16, 2017
EQ 80MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Nov 16, 2017
EQ 90MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Nov 16, 2017
EQ 105MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Nov 16, 2017
EQ 135MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Nov 16, 2017
EQ 65MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 16, 2023
EQ 115MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 16, 2023
EQ 55MG BASE	tablet, extended release	Discontinued	ORAL	N/A	Jun 16, 2023

Pharsight

Pharsight

Minocycline Hydrochloride Patents

Latest Legal Activities on Minocycline Hydrochloride's Patents

Minocycline Hydrochloride's Family Patents

Explore Our Curated Drug Screens

Minocycline Hydrochloride Generic API Manufacturers

1. ALKEM LABS LTD

2. ALVOGEN

Manufacturing Plant Locations New

3. AUROBINDO PHARMA

Manufacturing Plant Locations New

4. AUROBINDO PHARMA LTD

Manufacturing Plant Locations New

5. BARR LABS INC

6. BEXIMCO PHARMS USA

7. CHARTWELL RX

8. DR REDDYS LABS LTD

9. IMPAX LABS

10. IMPAX LABS INC

11. LEDERLE

12. MEDICIS

Manufacturing Plant Locations New

13. NEXUS PHARMS

14. NORVIUM BIOSCIENCE

15. RISING

Manufacturing Plant Locations New

16. SANDOZ

Manufacturing Plant Locations New

17. STRIDES PHARMA

Manufacturing Plant Locations New

18. SUN PHARM

Manufacturing Plant Locations New

19. SUN PHARM INDS INC

20. SUN PHARM INDS LTD

21. SUN PHARM INDUSTRIES

22. TORRENT

Manufacturing Plant Locations New

23. WATSON LABS

24. WATSON LABS TEVA

25. ZYDUS

Manufacturing Plant Locations New

26. ZYDUS PHARMS

Related content

Have Questions?

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New

Manufacturing Plant Locations
^New